GAIDANO, Gianluca
 Distribuzione geografica
Continente #
NA - Nord America 19.273
EU - Europa 18.654
AS - Asia 11.269
SA - Sud America 2.427
AF - Africa 351
Continente sconosciuto - Info sul continente non disponibili 73
OC - Oceania 30
Totale 52.077
Nazione #
US - Stati Uniti d'America 18.874
IE - Irlanda 5.567
SG - Singapore 3.896
DE - Germania 2.843
HK - Hong Kong 2.731
SE - Svezia 2.678
UA - Ucraina 2.191
CN - Cina 2.125
BR - Brasile 1.929
IT - Italia 1.504
RU - Federazione Russa 1.480
FI - Finlandia 1.190
VN - Vietnam 1.102
GB - Regno Unito 462
IN - India 375
KR - Corea 317
CA - Canada 223
AR - Argentina 204
FR - Francia 180
MX - Messico 127
ID - Indonesia 125
BD - Bangladesh 114
ZA - Sudafrica 114
BJ - Benin 103
PL - Polonia 85
EC - Ecuador 84
NL - Olanda 84
JP - Giappone 77
AT - Austria 74
EU - Europa 70
IR - Iran 69
ES - Italia 66
TR - Turchia 60
BE - Belgio 55
CZ - Repubblica Ceca 54
IQ - Iraq 53
LT - Lituania 51
CO - Colombia 50
VE - Venezuela 43
PY - Paraguay 42
EG - Egitto 29
PK - Pakistan 29
CL - Cile 28
PE - Perù 27
SY - Repubblica araba siriana 23
MA - Marocco 21
UZ - Uzbekistan 21
KE - Kenya 20
AU - Australia 19
DZ - Algeria 19
SA - Arabia Saudita 16
BG - Bulgaria 15
MY - Malesia 15
RO - Romania 15
IL - Israele 14
DO - Repubblica Dominicana 13
UY - Uruguay 13
AE - Emirati Arabi Uniti 12
TN - Tunisia 12
JO - Giordania 11
KZ - Kazakistan 11
ET - Etiopia 10
AL - Albania 9
CH - Svizzera 9
KG - Kirghizistan 9
NZ - Nuova Zelanda 9
AZ - Azerbaigian 8
NP - Nepal 7
OM - Oman 7
TW - Taiwan 7
HN - Honduras 6
HR - Croazia 6
NG - Nigeria 6
TT - Trinidad e Tobago 6
BH - Bahrain 5
JM - Giamaica 5
LB - Libano 5
RS - Serbia 5
CI - Costa d'Avorio 4
DK - Danimarca 4
GE - Georgia 4
MK - Macedonia 4
NI - Nicaragua 4
AM - Armenia 3
AO - Angola 3
BN - Brunei Darussalam 3
CR - Costa Rica 3
GR - Grecia 3
KW - Kuwait 3
LU - Lussemburgo 3
PA - Panama 3
PH - Filippine 3
PT - Portogallo 3
SI - Slovenia 3
SK - Slovacchia (Repubblica Slovacca) 3
SR - Suriname 3
A2 - ???statistics.table.value.countryCode.A2??? 2
BA - Bosnia-Erzegovina 2
BB - Barbados 2
BO - Bolivia 2
Totale 52.040
Città #
Dublin 5.550
Jacksonville 3.929
Hong Kong 2.728
Dearborn 1.869
Singapore 1.473
Chandler 1.333
Wilmington 1.277
Beijing 997
Ashburn 966
Lawrence 733
Princeton 732
Moscow 609
San Mateo 564
Los Angeles 516
Ho Chi Minh City 399
Andover 379
Piemonte 371
Buffalo 365
Seoul 314
Boardman 313
Ann Arbor 301
Hanoi 231
Houston 202
Woodbridge 199
São Paulo 172
New York 168
Novara 165
Munich 143
Redondo Beach 142
Hefei 135
Dallas 133
Philadelphia 116
Düsseldorf 115
Nanjing 110
Helsinki 109
Cotonou 103
Bremen 102
Kunming 98
Norwalk 91
Grafing 80
Frankfurt am Main 76
Milan 74
Montreal 74
London 71
Tokyo 69
Toronto 68
Warsaw 68
Nuremberg 66
Denver 63
Johannesburg 63
Brooklyn 61
Chennai 61
Mexico City 59
Rio de Janeiro 59
Poplar 58
Santa Clara 56
Seattle 53
Atlanta 52
Jinan 52
Stockholm 51
Brussels 50
Fairfield 50
Haiphong 50
Tianjin 50
Orem 49
Guangzhou 47
Turin 47
Phoenix 46
Chicago 43
Belo Horizonte 42
Curitiba 42
Brno 41
Boston 37
Brasília 37
Da Nang 37
Nanchang 37
Falkenstein 36
Jakarta 36
Rome 36
Vienna 34
Biên Hòa 32
Mumbai 31
Manchester 30
Porto Alegre 30
Vercelli 30
Amsterdam 29
Turku 29
San Francisco 28
Thái Bình 28
Zanjan 28
Guayaquil 27
Dhaka 26
Ankara 25
Ninh Bình 25
Quito 25
Falls Church 24
Shenyang 23
Campinas 21
Fuzhou 21
Salvador 21
Totale 30.966
Nome #
Fatality rate and predictors of mortality in an Italian cohort of hospitalized COVID-19 patients 206
Comparative Analysis of the Performance of Automated Digital Cell Morphology Analyzers for Leukocyte Differentiation in Hematologic Malignancies: Mindray MC‐80 Versus West Medical Vision Hema 187
A randomized clinical study on the impact of Comprehensive Geriatric Assessment (CGA) based interventions on the quality of life of elderly, frail, onco-hematologic patients candidate to anticancer therapy: protocol of the ONCO-Aging study 179
Multicentre validation of a prognostic index for overall survival in chronic lymphocytic leukaemia 160
Simple Parameters from Complete Blood Count Predict In-Hospital Mortality in COVID-19 152
Globalisation of industry-sponsored clinical trials for breast, lung and colon cancer research: trends, threats and opportunities 144
Analysis of SF3B1 mutations in monoclonal B-cell lymphocytosis 144
Analysis of human beta papillomavirus and Merkel cell polyomavirus infection in skin lesions and eyebrow hair bulbs from a cohort of chronic lymphocytic leukaemia patients. 140
Contribution of Atrial Fibrillation to In-Hospital Mortality in Patients With COVID-19 139
Alterations of negative regulators of cytokine signalling in immunodeficiency-related non-Hodgkin lymphoma 133
Diffuse large B-cell lymphoma genotyping on the liquid biopsy 133
Benefit sharing and globalisation of industry sponsored clinical trials for breast cancer research 133
The krüppel-like factor 2 transcription factor gene is recurrently mutated in splenic marginal zone lymphoma. 128
NOTCH1 mutations identify a chronic lymphocytic leukemia patient subset with worse prognosis in the setting of a rituximab-based induction and consolidation treatment. 127
Bendamustine and subcutaneous Alemtuzumab combination is an effective treatment in relapsed/refractory chronic lymphocytic leukemia patients. 125
IL LINFOMA PRIMITIVO DELLE SIEROSE E ALTRE MALATTIE LINFOPROLIFERATIVE ASSOCIATE AD HHV-8 125
The clinical implications of gene mutations in chronic lymphocytic leukaemia 124
6q DELETIONS DEFINE DISTINCT CLINICO-PATHOLOGIC SUBSETS OF NON-HODGKIN'S LYMPHOMA 123
Early progression of disease predicts shorter survival in MALT lymphoma patients receiving systemic treatment 123
Molecular lesions of signalling pathway genes in clonal B-cell lymphocytosis with marginal zone features. 122
Aberrant methylation in the promoter region of the reduced folate carrier gene is a potential mechanism of resistance to methotrexate in primary central nervous system lymphomas 116
Alteration of BIRC3 and multiple other NF-kB pathway genes in splenic marginal zone lymphoma 116
A ROLE FOR GROWTH HORMONE AND PROLACTIN IN LEUKAEMIA AND LYMPHOMA? 115
Integrated mutational and cytogenetic analysis identifies new prognostic subgroups in chronic lymphocytic leukemia 115
International Prognostic Score for Asymptomatic Early-stage Chronic Lymphocytic Leukemia 115
Decreased function of Fas and variations of the perforin gene in adult patients with primary immune thrombocytopenia 114
CLINICAL IMPLICATIONS OF THE MOLECULAR GENETICS OF CHRONIC LYMPHOCYTIC LEUKEMIA 113
ANALYSIS OF HUMAN HERPESVIRUS TYPE-8 INFECTION IN AIDS-RELATED AND AIDS-UNRELATED PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA 111
Beta-HPV infection and skin cancer in patients suffering from chronic lymphocytic leukemia. 109
Active AKT signaling triggers CLL towards Richter's transformation via over-activation of Notch1 109
Aberrant somatic hypermutation in transformation of follicular lymphoma and chronic lymphocytic leukemia to diffuse large B-cell lymphoma 108
ASSOCIATION BETWEEN MOLECULAR LESIONS AND SPECIFIC B-CELL RECEPTOR SUBSETS IN CHRONIC LYMPHOCYTIC LEUKEMIA 107
CLINICAL IMPACT OF SMALL SUBCLONES HARBORING NOTCH1, SF3B1 OR BIRC3 MUTATIONS IN CHRONIC LYMPHOCYTIC LEUKEMIA 107
MOLECULAR BASES OF CHRONIC LYMPHOCYTIC LEUKEMIA IN LIGHT OF NEW TREATMENTS 106
Extracellular nicotinamide phosphoribosyltransferase (NAMPT) promotes M2 macrophage polarization in chronic lymphocytic leukemia. 106
SIMIAN AIDS-RELATED LYMPHOMA GROWTH IN SCID MICE IS INDEPENDENT OF KARYOTYPIC ABNORMALITIES OR BCL-6 MUTATIONS 105
Progressive telomere shortening is part of the natural history of chronic lymphocytic leukaemia and impacts clinical outcome: evidences from long term follow-up 105
Biological and clinical implications of BIRC3 mutations in chronic lymphocytic leukemia 105
13q14 deletion size and number of deleted cells both influence prognosis in chronic lymphocytic leukemia 104
Analysis of the chronic lymphocytic leukemia coding genome: role of NOTCH1 mutational activation 104
CLINICAL IMPACT OF SMALL TP53 MUTATED SUBCLONES IN CHRONIC LYMPHOCYTIC LEUKEMIA 104
Factor VIII as a potential player in cancer pathophysiology 104
A 2-Mb YAC CONTIG LINKING THE PLASMINOGEN-APOPROTEIN(a) GENE FAMILY TO THE INSULIN-LIKE GROWTH FACTOR 2 RECEPTOR (IGF2R) GENE ON THE TELOMERIC REGION OF CHROMOSOME 6 (6q26-q27) 103
AIDS ASSOCIATED LYMPHOMAS ARE EFFICIENTLY LYSED THROUGH COMPLEMENT DEPENDENT CYTOTOXICITY (CDC) AND ANTIBODY-DEPENDENT CELLULAR CYTOTOXICITY (ADCC) BY RITUXIMAB 103
Clinical and molecular features of mucosa-associated lymphoid tissue (MALT) lymphomas of salivary glands 103
Different impact of NOTCH1 and SF3B1 mutations on the risk of chronic lymphocytic leukemia transformation to Richter syndrome 103
A NEW TAQ I POLYMORPHISM IN THE p53 GENE 102
Absence of NOTCH1 gene mutations in MALT lymphomas 102
The coding genome of splenic marginal zone lymphoma: activation of NOTCH2 and other pathways regulating marginal zone development 102
Recurrent mutations refine prognosis in chronic lymphocytic leukemia. 101
HUMAN NORMAL CD5+ B LYMPHOCYTES CAN BE INDUCED TO DIFFERENTIATE TO CD5- B LYMPHOCYTES WITH GERMINAL CENTER CELL FEATURES 101
ASSOCIATION OF KSHV POSITIVE PRIMARY EFFUSION LYMPHOMA WITH EXPRESSION OF THE CD138/SYNDECAN-1 ANTIGEN 101
A variant of the LRP4 gene affects the risk of chronic lymphocytic leukaemia transformation to Richter syndrome 101
A B-cell receptor-related gene signature predicts survival in mantle cell lymphoma: results from the "Fondazione Italiana Linfomi" MCL-0208 trial 101
Clues to the pathogenesis of Waldenström Macroglobulinemia and IgM-MGUS provided by the analysis of immunoglobulin heavy chain gene rearrangement and clustering of B-cell receptors 101
Biology and treatment of Richter syndrome 100
Mutations of NOTCH1 are an independent predictor of survival in chronic lymphocytic leukemia 100
LINFOMI NON-HODGKIN (NHL) E LINFOMA DI HODGKIN (HD) ASSOCIATI ALL'INFEZIONE DA HIV. CARATTERISTICHE EPIDEMIOLOGICHE, PATOLOGICHE, MOLECOLARI E CLINICHE NELL'ERA DELL'HAART 99
ALTERAZIONI GENETICHE E INTERAZIONI CON IL MICROAMBIENTE NEI LINFOMI MALIGNI 98
Aberrant somatic hypermutation in post-transplant lymphoproliferative disorders 98
Extrahepatic sources of factor VIII potentially contribute to the coagulation cascade correcting the bleeding phenotype of mice with hemophilia A 98
Clinical, pathological, and biological characterization of Richter syndrome developing after ibrutinib treatment for relapsed chronic lymphocytic leukemia 98
MOLECULAR INVESTIGATION OF THE CYTOKINES PRODUCED BY NORMAL AND MALIGNANT B LYMPHOCYTES 97
Alternative translocation breakpoint cluster region 5' to BCL-6 in B-cell non-Hodgkin's lymphoma 97
Analysis of immunoglobulin heavy and light chain variable genes in post-transplant lymfoproliferative disorders 97
The genetics of nodal marginal zone lymphoma 96
European education corridors: opportunity for academic solidarity 96
Presenting features and early mortality from SARS-CoV-2 infection in cancer patients during the initial stage of the COVID-19 pandemic in Europe 96
Prevalence and impact of COVID-19 sequelae on treatment pathways and survival of patients with cancer who recovered from SARS-Cov-2 infection: results from the OnCovid registry. 96
SAC I RFLP IN THE INSULIN-LIKE GROWTH FACTOR 2 RECEPTOR GENE (IGF2R) ON HUMAN CHROMOSOME 6q 95
Beta-HPV infection and skin cancer in patients suffering from chronic lymphocytic leukemia. 95
Analysis of the host pharmacogenetic background for prediction of outcome and toxicity in diffuse large B-cell lymphoma treated with R-CHOP21 95
MGA, a suppressor of MYC, is recurrently inactivated in high risk chronic lymphocytic leukemia 95
MOLECULAR PATHOPHYSIOLOGY OF INDOLENT LYMPHOMA 94
MOLECULAR BASIS OF TARGET THERAPY FOR AGGRESSIVE B-CELL LYMPHOMA 94
Analysis of NOTCH1 mutations in monoclonal B cell lymphocytosis 94
A novel role of the CX3CR1/CX3CL1 system in the cross-talk between chronic lymphocytic leukemia cells and tumor microenvironment 94
BCL2 MUTATION SPECTRUM IN B-CELL NON-HODGKIN LYMPHOMAS AND PATTERNS ASSOCIATED WITH EVOLUTION OF FOLLICULAR LYMPHOMA 93
ESTABLISHMENT OF AIDS-RELATED LYMPHOMA CELL LINES FROM LYMPHOMATOUS EFFUSIONS 93
Mutations of the SF3B1 splicing factor in chronic lymphocytic leukemia: association with progression and fludarabine-refractoriness 93
Disruption of BIRC3 associates with fludarabine chemorefractoriness in TP53 wild type chronic lymphocytic leukemia 93
Once-weekly carfilzomib, pomalidomide, and low-dose dexamethasone for relapsed/refractory myeloma: a phase I/II study 93
Targeting p53 in chronic lymphocytic leukemia 93
Chromosome 1 abnormalities in newly diagnosed elderly multiple myeloma patients treated with novel therapies. 92
STRUCTURAL AND FUNCTIONAL ANALYSIS OF ONCOGENES AND TUMOR SUPPRESSOR GENES IN ADULT T-CELL LEUKEMIA/LYMPHOMA SHOWS FREQUENT p53 MUTATIONS 92
HIV-ASSOCIATED HHV-8 POSITIVE PRIMARY LYMPHOMATOUS EFFUSIONS: RADIOLOGICAL FINDINGS IN SIX PATIENTS 92
PATTERNS OF CYTOKINE EXPRESSION IN AIDS-RELATED NON-HODGKIN'S LYMPHOMA 92
Genetic determinants of response to warfarin. 92
Aberrant somatic hypermutation in primary mediastinal large B-cell lymphoma 92
Potential of BCL2 as a target for chronic lymphocytic leukemia treatment 92
A leukemia-protective germline variant mediates chromatin module formation via transcription factor nucleation 92
MYC NETWORK MUTATIONS IN HIGH-RISK CHRONIC LYMPHOCYTIC LEUKAEMIA 91
KAPOSI's SARCOMA-ASSOCIATED HERPESVIRUS DNA SEQUENCES IN AIDS-RELATED AND AIDS-UNRELATED LYMPHOMATOUS EFFUSIONS 91
MOLECULAR PATHOGENESIS OF NON-HODGKIN LYMPHOMA: A CLINICAL PERSPECTIVE 90
EXPRESSION OF MUM-1/IRF4 SELECTIVELY CLUSTERS WITH PRIMARY EFFUSION LYMPHOMA AMONG LYMPHOMATOUS EFFUSIONS. IMPLICATIONS FOR DISEASE HISTOGENESIS AND PATHOGENESIS 90
Clinical portrait of the SARS-CoV-2 epidemic in European cancer patients 90
Libro universitario: Letteratura, medicina e scienze sociali. Convergenze tra culture e linguaggi; Chapter- Per un’etica della condivisione dei benefici in tema di sperimentazione dei farmaci 90
Clonally unrelated Richter syndrome are truly de novo diffuse large B-cell lymphomas with a mutational profile reminiscent of clonally related Richter syndrome 89
TAQI RFLP IN THE INTERFERON GAMMA RECEPTOR 1 GENE (IFNGR1) ON HUMAN CHROMOSOME 6q 89
Genetic determinants of response to warfarin. 89
Totale 10.794
Categoria #
all - tutte 310.035
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 310.035


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20212.537 0 0 0 0 0 54 707 33 710 66 826 141
2021/20224.996 122 26 992 587 342 78 488 117 325 140 805 974
2022/202310.113 807 313 461 399 575 833 201 459 5.554 29 298 184
2023/20243.104 241 214 246 76 585 50 630 78 23 41 215 705
2024/20258.283 182 63 257 173 245 473 646 843 2.767 882 332 1.420
2025/202610.876 1.029 893 2.116 3.717 1.947 1.174 0 0 0 0 0 0
Totale 52.927